The Transplantation Immunosuppressive Pharmacology Research Program (TIPRP) at the University at Buffalo (UB) is a multidisciplinary research program in clinical pharmacology research in the areas of chronic kidney disease and renal transplantation. The TIPRP emphasizes pharmacokinetics, pharmacodynamics and pharmacogenomics of immunosuppressive medicines for over 20 years. This program is a component of the Translational Pharmacology Research Core (TPRC) laboratory facility. The TIPRP is located in the School of Pharmacy and Pharmaceutical Sciences on South Campus at UB and the Nephrology Division at the Erie County Medical Center. This research program has contributed many publications that report on the influence of gender and race on immunosuppressive medicines after kidney transplant.
The Nurse Practitioner position is seeking a Registered Nurse Practitioner – New York State (RPA) and includes the following responsibilities:
- Complete Patient Screening – Case Report Forms in renal transplant recipients with understanding of the disease processes and drug therapy in adequate detail and in a timely fashion to facilitate patient enrollment.
- Provide medical updates on renal transplant recipients that receive medical care through the Divisions of Nephrology and Transplantation
- Assist in patient recruitment and enrollment of renal transplant recipients from ages 22 to 85 in the UB-MD Transplant and Nephrology Clinics at Erie County Medical Center (ECMC) or by direct patient communication maintaining proper documentation.
Ability to use nursing skills to effectively evaluate, and respond to enrolled patient’s clinical responses over the course of the 12-hour pharmacokinetic and pharmacodynamic (PK/PD) study period and provide/obtain appropriate medical intervention and maintain documentation.
- Ability to administer and complete the study consent process after completion of required training through Collaborative Institutional Training Initiative (CITI Program) for Biomedical Research, Good Research Practices and HIPAA and other required training mandated by the Institutional Review Board at University at Buffalo.
- Ability to accurately collect and enter clinical data into web based data collection forms from patients’ clinical information from the study period.
- Provide monthly updated summaries regarding screening, patient enrollment relative to targets and follow-up patient outcomes over the 12-hour pharmacokinetic-pharmacodynamic study period.
- Timely documentation and communication of changes in acute or chronic medical conditions in patients enrolled in the clinical pharmacology study.
- This research Nurse Practitioner must demonstrate HIPAA compliance by completion of the appropriate certificate of verification for the required CITI tutorials by UB Human Subject Investigational Review Board (HS-IRB) and the Principal Investigator.
- Provide very good communication skills with patients and research staff regarding medical or psychosocial changes in the targeted renal transplant recipients that are currently or may be eligible for subject enrollment in the clinical pharmacology study.
The University at Buffalo is SUNY’s most comprehensive public research university, and an outstanding place to work. UB amplifies ambition for faculty and staff by offering endless possibilities to achieve more. Here, people from all backgrounds and cultures challenge and inspire each other to discover, learn and succeed. Dedicated staff and engaged faculty collaborate to further knowledge and understanding, and develop tenacious graduates who are valued for their talents and their impact on global society. Visit our website to learn more about the http://buffalo.edu/University at Buffalo.
As an Equal Opportunity / Affirmative Action employer, the Research Foundation will not discriminate in its employment practices due to an applicant’s race, color, religion, sex, sexual orientation, gender identity, national origin and veteran or disability status